ATNM vs AZO · rev $35.0M vs P/E 21, rev $18.94B
Actinium Pharmaceuticals Inc (ATNM) versus AutoZone Inc (AZO) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
ATNM currently screens at market cap $33.9M. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Not investment advice. Open the ATNM and AZO stock pages for the full models.
Not investment advice.